Literature DB >> 6097171

Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem.

R M Bannatyne, R Cheung.   

Abstract

The in vitro activities of 16 cephalosporin derivatives and imipenem against 60 strains of Bordetella pertussis were examined. Cefoperazone, imipenem, and ceftriaxone were the most active, with MICs that inhibited 90% of the strains of 0.006, 0.05, and 0.1 microgram/ml, respectively. Cephalexin, cephradine, and cefsulodin were the least active, with MICs of 25 to 125 micrograms/ml. The remainder of the agents demonstrated intermediate activity.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6097171      PMCID： PMC179976          DOI： 10.1128/AAC.26.4.604

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Enrichment medium for the isolation of Bordetella.

Authors:  J Regan; F Lowe
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

2.  Selective medium for the isolation of bordetella pertussis and parapertussis.

Authors:  E M Sutcliffe; J D Abbott
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

3.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

Review 4.  The new beta-lactamase-stable cephalosporins.

Authors:  H C Neu
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391
  4 in total
  9 in total

Review 1.  Methods for isolation of Bordetella pertussis from patients with whooping cough.

Authors:  J E Hoppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

2.  Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.

Authors:  T A Kurzynski; D M Boehm; J A Rott-Petri; R F Schell; P E Allison
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 3.  Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

4.  Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Hoppe; T Tschirner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 5.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

6.  In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins.

Authors:  J E Hoppe; J Müller
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 7.  Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.

Authors:  G L Kearns; R A Young
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

Review 8.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 9.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.